Description
An alkaloid with diverse biological activities; a CB1 receptor antagonist (IC50 = 41 nM); time- and dose-dependently decreases survival of U2OS and U2OS/DX osteosarcoma cells and induces autophagy, but not apoptosis, at 1-10 µg/ml; inhibits growth of P. falciparum in vitro and reduces parasitemia in mice infected with P. yoelii when administered at doses of 2.5, 5, and 10 mg/kg
Formal name: 12-methoxy-13-[(3α)-17-methoxy-17-oxovobasan-3-yl]-ibogamine-18-carboxylic acid, methyl ester
Synonyms: NSC 82591
Molecular weight: 704.9
CAS: 3371-85-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Product Type|Biochemicals|Natural Products|Alkaloids||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer|Autophagy||Research Area|Cancer|Cell Death||Research Area|Cancer|Multidrug Resistance||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Malaria||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors